{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T09:21:33Z","timestamp":1789464093892,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd007231.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,5,5]],"date-time":"2019-05-05T00:00:00Z","timestamp":1557014400000}}],"reference-count":105,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007231.pub3","type":"journal-article","created":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T16:17:00Z","timestamp":1557159420000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Stem cell transplantation for ischemic stroke"],"prefix":"10.1002","volume":"2019","author":[{"given":"Giorgio Battista","family":"Boncoraglio","sequence":"first","affiliation":[{"name":"Fondazione IRCCS Istituto Neurologico \"Carlo Besta\"; Department of Neurology; Via Celoria 11 Milano Italy 20133"},{"name":"Universit\u00e0 di Milano - Bicocca; PhD Program in Neuroscience; Monza Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Ranieri","sequence":"additional","affiliation":[{"name":"Fondazione IRCCS Istituto Neurologico \"Carlo Besta\"; Department of Neurology; Via Celoria 11 Milano Italy 20133"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bersano","sequence":"additional","affiliation":[{"name":"Fondazione IRCCS Istituto Neurologico \"Carlo Besta\"; Department of Neurology; Via Celoria 11 Milano Italy 20133"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio A","family":"Parati","sequence":"additional","affiliation":[{"name":"Fondazione IRCCS Istituto Neurologico \"Carlo Besta\"; Department of Neurology; Via Celoria 11 Milano Italy 20133"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Del Giovane","sequence":"additional","affiliation":[{"name":"University of Bern; Institute of Primary Health Care (BIHAM); Gesellschaftsstrasse 49 Bern Switzerland 3012"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,5,5]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD007231.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/ana.20501","article-title":"Autologous mesenchymal stem cell transplantation in stroke patients","volume":"57","author":"Bang","year":"2005","journal-title":"Annals of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD007231.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3174\/ajnr.A5586","article-title":"Randomized assessment of the safety and efficacy of intra-arterial infusion of autologous stem cells in subacute ischemic stroke","volume":"39","author":"Bhatia","year":"2018","journal-title":"American Journal of Neuroradiology"},{"issue":"1S","key":"10.1002\/14651858.CD007231.pub3-BIB0003|cit3","first-page":"483","article-title":"Safety and efficacy of intra-arterial infusion of bone marrow derived mononuclear cells in subacute ischemic stroke: randomized open labeled clinical trial","volume":"2","author":"Khurana","year":"2017","journal-title":"European Stroke Journal"},{"issue":"1S","key":"10.1002\/14651858.CD007231.pub3-BIB0004|cit4","first-page":"128","article-title":"Safety and clinical outcome of intraarterial infusion of bone marrow derived mononuclear cells in subacute ischemic stroke: randomized open labeled blinded end point clinical pilot trial","volume":"3","author":"Singh","year":"2018","journal-title":"European Stroke Journal"},{"issue":"12","key":"10.1002\/14651858.CD007231.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.3727\/096368914X678562","article-title":"Intracerebral implantation of autologous peripheral blood stem cells in stroke patients: a randomized phase II study","volume":"23","author":"Chen","year":"2014","journal-title":"Cell Transplantation"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"A71","DOI":"10.1161\/str.47.suppl_1.71","article-title":"Final results of the B01-02 phase 2 trial testing the safety and efficacy of MultiStem in treatment of ischemic stroke","volume":"47","author":"Hess","year":"2016","journal-title":"Stroke"},{"issue":"3","key":"10.1002\/14651858.CD007231.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/ijs.12065","article-title":"A double-blind placebo-controlled clinical evaluation of MultiStem for the treatment of ischemic stroke","volume":"9","author":"Hess","year":"2014","journal-title":"International Journal of Stroke"},{"issue":"5","key":"10.1002\/14651858.CD007231.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S1474-4422(17)30046-7","article-title":"Safety and efficacy of multipotent adult progenitor cells in acute Ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"16","author":"Hess","year":"2017","journal-title":"Lancet Neurology"},{"issue":"2","key":"10.1002\/14651858.CD007231.pub3-BIB0009|cit9","first-page":"3059","article-title":"Analysis of the long-term effect of bone marrow mononuclear cell transplantation for the treatment of cerebral infarction","volume":"10","author":"Jin","year":"2017","journal-title":"International Journal of Clinical and Experimental Medicine"},{"issue":"6","key":"10.1002\/14651858.CD007231.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/stem.430","article-title":"A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke","volume":"28","author":"Lee","year":"2010","journal-title":"Stem Cells"},{"issue":"12","key":"10.1002\/14651858.CD007231.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1161\/STROKEAHA.114.007028","article-title":"Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial","volume":"45","author":"Prasad","year":"2014","journal-title":"Stroke"},{"issue":"11","key":"10.1002\/14651858.CD007231.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.5966\/sctm.2013-0178","article-title":"Intra-arterial immunoselected CD34+ stem cells for acute ischemic stroke","volume":"3","author":"Banerjee","year":"2014","journal-title":"Stem Cells Translational Medicine"},{"issue":"1","key":"10.1002\/14651858.CD007231.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2217\/rme.10.97","article-title":"Safety of autologous bone marrow mononuclear cell transplantation in patients with non acute ischemic stroke","volume":"6","author":"Battistella","year":"2011","journal-title":"Regenerative Medicine"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"93-104","DOI":"10.1159\/000333381","article-title":"Autologous mesenchymal stem cells in chronic stroke","volume":"1","author":"Bhasin","year":"2011","journal-title":"Cerebrovascular Diseases Extra"},{"issue":"7","key":"10.1002\/14651858.CD007231.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.clineuro.2012.10.015","article-title":"Stem cell therapy: a clinical trial of stroke","volume":"115","author":"Bhasin","year":"2013","journal-title":"Clinical Neurology and Neurosurgery"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"521-9","DOI":"10.1002\/sctm.18-0008","article-title":"Allogeneic umbilical cord blood infusion for adults with ischemic stroke: clinical outcomes from a phase 1 safety study","volume":"7","author":"Laskowitz","year":"2018","journal-title":"Stem Cells Translational Medicine"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.3727\/096368912X612512","article-title":"Intra-arterial infusion of autologous bone marrow mononuclear cells in patients with moderate to severe middle cerebral artery acute ischemic stroke","volume":"21 Suppl 1","author":"Friedrich","year":"2012","journal-title":"Cell Transplantation"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3389\/fneur.2016.00228","article-title":"Intra-arterial infusion of autologous bone marrow mononuclear stem cells in subacute ischemic stroke patients","volume":"7","author":"Ghali","year":"2016","journal-title":"Frontiers in Neurology"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/brain\/awr063","article-title":"Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke","volume":"134","author":"Honmou","year":"2011","journal-title":"Brain"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0020|cit20","unstructured":"ISRCTN15677760 The therapeutic effect of autologous peripheral blood-derived stem cell therapy on acute brain infarcts isrctn.com\/ISRCTN15677760"},{"issue":"4","key":"10.1002\/14651858.CD007231.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1212\/WNL.55.4.565","article-title":"Transplantation of cultured human neuronal cells for patients with stroke","volume":"55","author":"Kondziolka","year":"2000","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD007231.pub3-BIB0022|cit22","first-page":"586","article-title":"Serial [18F] fluorodeoxyglucose positron emission tomography after human neuronal implantation for stroke","volume":"49","author":"Meltzer","year":"2001","journal-title":"Neurosurgery"},{"issue":"4","key":"10.1002\/14651858.CD007231.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0002-9440(10)62546-1","article-title":"Clonal human (hNT) neuron grafts for stroke therapy: neuropathology in a patient 27 months after implantation","volume":"160","author":"Nelson","year":"2002","journal-title":"American Journal of Pathology"},{"issue":"24","key":"10.1002\/14651858.CD007231.pub3-BIB0024|cit24","first-page":"4781","article-title":"Sterile preparation of umbilical cord derived mesenchymal stem cells with multiple bags: method and effect","volume":"11","author":"Li","year":"2007","journal-title":"Journal of Clinical Rehabilitative Tissue Engineering Research"},{"issue":"4","key":"10.1002\/14651858.CD007231.pub3-BIB0025|cit25","first-page":"472","article-title":"CD34+ stem cell therapy in chronic stroke patients - Phase I trial","volume":"17","author":"Lin","year":"2008","journal-title":"Cell Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD007231.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/WNQ.0b013e31825a6adf","article-title":"Clinical transplantation of human embryonic neural stem cells for the treatment of cerebral infarction sequelae","volume":"23","author":"Lu","year":"2013","journal-title":"Neurosurgery Quarterly"},{"issue":"7","key":"10.1002\/14651858.CD007231.pub3-BIB0027|cit27","first-page":"618","article-title":"Vein transplantation using human umbilical cord blood stem cells in the treatment of stroke sequela","volume":"1","author":"Man","year":"2006","journal-title":"Neural Regeneration Research"},{"issue":"4","key":"10.1002\/14651858.CD007231.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2217\/17460751.2.4.417","article-title":"Potential roles of bone marrow stem cells in stroke therapy","volume":"2","author":"Mendez-Otero","year":"2007","journal-title":"Regenerative Medicine"},{"issue":"1","key":"10.1002\/14651858.CD007231.pub3-BIB0029|cit29","first-page":"52","article-title":"Intra-arterial autologous bone marrow mononuclear cell transplantation for acute ischemic stroke","volume":"86","author":"Mendon\u00e7a","year":"2006","journal-title":"Arquivos Brasileiros de Cardiologia"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0030|cit30","unstructured":"Meng X-G Zhu S-W Gao H Li Z Shi Q Hou H-S Treatment of cerebral infarction using autologous marrow mesenchymal stem cells transplantation: a six-month follow-up Journal of Clinical Rehabilitative Tissue Engineering Research 2009 6374 8"},{"issue":"6 Supplement","key":"10.1002\/14651858.CD007231.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/j.jcyt.2016.03.020","article-title":"BM-MSC accelerates acute stroke recovery in a randomized placebo-controlled clinical phase II\/III study","volume":"18","author":"Mohamed Ibrahim","year":"2016","journal-title":"Cytotherapy"},{"issue":"8","key":"10.1002\/14651858.CD007231.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1161\/STROKEAHA.112.659409","article-title":"Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial","volume":"43","author":"Moniche","year":"2012","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.3727\/096368914X684934","article-title":"Intra-arterial bone marrow mononuclear cell transplantation correlates with GM-CSF, PDGF-BB, and MMP-2 serum levels in stroke patients: results from a clinical trial","volume":"23 Suppl 1","author":"Moniche","year":"2014","journal-title":"Cell Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD007231.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/1747493016641111","article-title":"TOOTH (The Open study Of dental pulp stem cell Therapy in Humans): study protocol for evaluating safety and feasibility of autologous human adult dental pulp stem cell therapy in patients with chronic disability after stroke","volume":"11","author":"Nagpal","year":"2016","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0035|cit35","unstructured":"NCT01297413 A study of allogeneic mesenchymal bone marrow cells in subjects with ischemic stroke clinicalTrials.gov\/show\/NCT01297413"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0036|cit36","unstructured":"NCT02397018 Cord blood infusion for ischemic stroke clinicalTrials.gov\/show\/NCT02397018"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0037|cit37","unstructured":"NCT02795052 Neurologic Stem cell Treatment study (NEST) clinicalTrials.gov\/show\/NCT02795052"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0038|cit38","unstructured":"NCT03296618 Intracerebral transplantation of neural stem cells for the treatment of ischemic stroke clinicaltrials.gov\/show\/NCT03296618"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0039|cit39","unstructured":"NCT03384433 Allogenic mesenchymal stem cell derived exosome in patients with acute ischemic stroke clinicaltrials.gov\/show\/NCT03384433"},{"issue":"10046","key":"10.1002\/14651858.CD007231.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0140-6736(16)30513-X","article-title":"Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study","volume":"388","author":"Kalladka","year":"2016","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0041|cit41","first-page":"S109","article-title":"Neural stem cells in ischaemic stroke: from bench-to-bedside","volume":"259 Suppl 1","author":"Muir","year":"2012","journal-title":"Journal of Neurology"},{"issue":"1S","key":"10.1002\/14651858.CD007231.pub3-BIB0042|cit42","first-page":"484","article-title":"Ctx human stem cells in stroke recovery: 6 month outcomes of the pilot investigation of stem cells in stroke phase 2 efficacy (PISCES II) study","volume":"2","author":"Bulters","year":"2017","journal-title":"European Stroke Journal"},{"issue":"2","key":"10.1002\/14651858.CD007231.pub3-BIB0043|cit43","first-page":"221","article-title":"Autologous intravenous bone marrow mononuclear cell therapy for patients with subacute ischaemic stroke: a pilot study","volume":"136","author":"Prasad","year":"2012","journal-title":"Indian Journal of Medical Research"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0044|cit44","doi-asserted-by":"crossref","unstructured":"Qiao L Huang F Zhao M Xie J Shi J Wang J A two-year follow-up study of cotransplantation with neural stem\/progenitor cells and mesenchymal stromal cells in ischemic stroke patients Cell Transplantation 2014 S65-72","DOI":"10.3727\/096368914X684961"},{"issue":"1","key":"10.1002\/14651858.CD007231.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s10517-005-0229-y","article-title":"Cell therapy of brain stroke","volume":"139","author":"Rabinovich","year":"2005","journal-title":"Bulletin of Experimental Biology and Medicine"},{"issue":"2","key":"10.1002\/14651858.CD007231.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000086518","article-title":"Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study","volume":"20","author":"Savitz","year":"2005","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0047|cit47","doi-asserted-by":"crossref","unstructured":"Savitz SI Misra V Kasam M Juneja H Cox CS Jr Alderman S Intravenous autologous bone marrow mononuclear cells for ischemic stroke Annals of Neurology 2011 59-69","DOI":"10.1002\/ana.22458"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0048|cit48","doi-asserted-by":"crossref","unstructured":"Sharma A Sane H Gokulchandran N Khopkar D Paranjape A Sundaram J Autologous bone marrow mononuclear cells intrathecal transplantation in chronic stroke Stroke Research and Treatment 2014 234095","DOI":"10.1155\/2014\/234095"},{"issue":"2","key":"10.1002\/14651858.CD007231.pub3-BIB0049|cit49","first-page":"234","article-title":"ReN001, a stem cell therapy for stroke disability","volume":"18","author":"Sinden","year":"2009","journal-title":"Cell Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD007231.pub3-BIB0050|cit50","first-page":"784","article-title":"A novel phase 1\/2A study of intraparenchymal transplantation of human modified bone marrow-derived cells in patients with stable ischemic stroke","volume":"23","author":"Steinberg","year":"2014","journal-title":"Cell Transplantation"},{"issue":"7","key":"10.1002\/14651858.CD007231.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1161\/STROKEAHA.116.012995","article-title":"Clinical outcomes of transplanted modified bone marrow-derived mesenchymal stem cells in stroke: a phase 1\/2a study","volume":"47","author":"Steinberg","year":"2016","journal-title":"Stroke"},{"issue":"3","key":"10.1002\/14651858.CD007231.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3233\/RNN-2009-0483","article-title":"Autologous bone marrow stem cell neurotransplantation in stroke patients. An open study","volume":"27","author":"Su\u00e1rez-Monteagudo","year":"2009","journal-title":"Restorative Neurology and Neuroscience"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0053|cit53","doi-asserted-by":"crossref","unstructured":"Taguchi A Sakai C Soma T Kasahara Y Stern DM Kajimoto K Intravenous autologous bone marrow mononuclear cell transplantation for stroke: phase1\/2a clinical trial in a homogeneous group of stroke patients Stem Cells and Development 2015 2207 18","DOI":"10.1089\/scd.2015.0160"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0054|cit54","unstructured":"Vahidy F Kar S Aisiku I Juneja H Lee D Garret J Safety of intravenous mononuclear cells for acute stroke (SIVMAS) trial Cell Transplantation 2012 795"},{"issue":"6","key":"10.1002\/14651858.CD007231.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.3174\/ajnr.A4232","article-title":"Qualitative and quantitative analysis of MR imaging findings in patients with middle cerebral artery stroke implanted with mesenchymal stem cells","volume":"36","author":"Wanamaker","year":"2015","journal-title":"American Journal of Neuroradiology"},{"issue":"20","key":"10.1002\/14651858.CD007231.pub3-BIB0056|cit56","first-page":"3994","article-title":"Autologous bone marrow-derived mononuclear cell transplant for treatment of nervous system damage and degenerative disease: a report of 42 cases","volume":"11","author":"Wang","year":"2007","journal-title":"Journal of Clinical Rehabilitative Tissue Engineering Research"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"128591","DOI":"10.1155\/2013\/128591","article-title":"Intrathecal administration of autologous CD34 positive cells in patients with past cerebral infarction: a safety study","volume":"2013","author":"Wang","year":"2013","journal-title":"ISRN Neurology"},{"issue":"9","key":"10.1002\/14651858.CD007231.pub3-BIB0058|cit58","first-page":"208","article-title":"Functional evaluation of stroke patients 6 months after intrathecal injection of neural stem cells","volume":"9","author":"Yang","year":"2005","journal-title":"Chinese Journal of Clinical Rehabilitation"},{"issue":"20","key":"10.1002\/14651858.CD007231.pub3-BIB0059|cit59","first-page":"4033","article-title":"Neural stem cell transplantation for treating stroke sequela in 59 cases","volume":"11","author":"Yang","year":"2007","journal-title":"Journal of Clinical Rehabilitative Tissue Engineering Research"},{"issue":"9","key":"10.1002\/14651858.CD007231.pub3-BIB0060|cit60","first-page":"138","article-title":"Clinical analysis of neural stem cells for treatment of sequela in 50 stroke patients","volume":"10","author":"Zhang","year":"2006","journal-title":"Chinese Journal of Clinical Rehabilitation"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0061|cit61","unstructured":"ChiCTR-INR-16008908 Allogenic bone marrow-derived mesenchymal stem cells transplantation in severe cerebral infarction patients: a randomized controlled clinical trial www.chictr.org.cn\/showprojen.aspx?proj=14716"},{"issue":"1","key":"10.1002\/14651858.CD007231.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3171\/jns.2005.103.1.0038","article-title":"Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial","volume":"103","author":"Kondziolka","year":"2005","journal-title":"Journal of Neurosurgery"},{"issue":"7","key":"10.1002\/14651858.CD007231.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1212\/01.WNL.0000140700.44904.53","article-title":"Changes in cognitive function after neuronal cell transplantation for basal ganglia stroke","volume":"63","author":"Stilley","year":"2004","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0064|cit64","unstructured":"NCT01310114 Study of human placenta-derived cells (PDA001) to evaluate the safety and effectiveness for patients with ischemic stroke clinicaltrials.gov\/show\/NCT01310114"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0065|cit65","unstructured":"NCT01468064 Autologous bone marrow stromal cell and endothelial progenitor cell transplantation in ischemic stroke (AMETIS) clinicaltrials.gov\/show\/NCT01468064"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0066|cit66","unstructured":"NCT01518231 Autologous hematopoietic stem cell transplantation in ischemic stroke (AHSCTIS) clinicaltrials.gov\/show\/NCT01518231"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0067|cit67","unstructured":"NCT02378974 Evaluation of the safety and potential therapeutic effects after intravenous transplantation of Cordstem-ST in patients with cerebral infarction clinicaltrials.gov\/show\/NCT02378974"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0068|cit68","unstructured":"NCT02564328 Autologous bone marrow mesenchymal stem cell transplantation for chronic ischemic stroke clinicaltrials.gov\/show\/NCT02564328"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0069|cit69","unstructured":"NCT02605707 Autologous endothelial progenitor cells transplantation for chronic ischemic stroke clinicaltrials.gov\/show\/NCT02605707"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0070|cit70","unstructured":"NCT03176498 Human umbilical cord mesenchymal stem cell therapy for cerebral infarction patients in convalescent period clinicaltrials.gov\/show\/NCT03176498"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0071|cit71","unstructured":"NCT03186456 The safety and efficacy of human umbilical cord mesenchymal stem cells in the treatment of acute cerebral infarction clinicaltrials.gov\/show\/NCT03186456"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0072|cit72","unstructured":"Sych N Klunnyk M lvankova O Matiyaschuk I Cognitive functions and S-100 protein in acute brain infarction after fetal stem cells 8th World Stroke Congress; 2012 Oct 10-13; Brasilia (Brazil) 2012"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"ATMP32","DOI":"10.1161\/str.47.suppl_1.tmp32","article-title":"Intra-arterial ALD401 cell therapy is associated with reduction in stroke volume at 90 days in a subset of the RECOVER-stroke trial","volume":"47","author":"Atchaneeyasakul","year":"2016","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0074|cit74","first-page":"1-76","article-title":"Intra-arterial delivery of autologous ALDHbr cells in ischemic stroke: final 1-year results of the recover-stroke trial","volume":"10 Suppl 2","author":"Yavagal","year":"2015","journal-title":"International Journal of Stroke"},{"issue":"3","key":"10.1002\/14651858.CD007231.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000446404","article-title":"Paracrine mechanisms of intravenous bone marrow-derived mononuclear stem cells in chronic ischemic stroke","volume":"6","author":"Bhasin","year":"2016","journal-title":"Cerebrovascular Diseases Extra"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0076|cit76","first-page":"47 (AWP146)","article-title":"Intravenous bone marrow derived mononuclear stem cells in chronic ischemic stroke-paracrine mechanisms of recovery","volume":"47 Suppl 1","author":"Bhasin","year":"2016","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0077|cit77","unstructured":"Detante O Jaillard A Moisan A Favre I Barbieux M Garambois K Intravenous injection of autologous mesenchymal stem cells after ischemic stroke (ISIS\/HERMES): protocol and progress Cerebrovascular Diseases 2013 852"},{"issue":"10","key":"10.1002\/14651858.CD007231.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.06.011","article-title":"Reparative therapy for acute ischemic stroke with allogeneic mesenchymal stem cells from adipose tissue: a safety assessment: a phase II randomized, double-blind, placebo-controlled, single-center, pilot clinical trial","volume":"23","author":"D\u00edez-Tejedor","year":"2014","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"issue":"4","key":"10.1002\/14651858.CD007231.pub3-BIB0079|cit79","first-page":"649","article-title":"Phase III clinical trial using autologous mesenchymal stem cells for stroke patients","volume":"74","author":"Honmou","year":"2016","journal-title":"Nihon Rinsho"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/1745-6215-14-317","article-title":"Intravenous transplantation of mesenchymal stem cells preconditioned with early phase stroke serum: current evidence and study protocol for a randomized trial","volume":"14","author":"Kim","year":"2013","journal-title":"Trials"},{"issue":"7","key":"10.1002\/14651858.CD007231.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/ijs.12520","article-title":"Intra-arterial bone marrow mononuclear cells (BM-MNCs) transplantation in acute ischemic stroke (IBIStrial): protocol of a phase II, randomised, dose-finding, controlled multicenter trial","volume":"10","author":"Moniche","year":"2015","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0082|cit82","unstructured":"NCT02448641 Study of modified stem cells (SB623) in patients with chronic motor deficit from ischemic stroke (ACTIsSIMA) clinicaltrials.gov\/ct2\/show\/NCT02448641"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0083|cit83","unstructured":"NCT02580019 Umbilical cord derived mesenchymal stem cells treatment in ischemic stroke clinicaltrials.gov\/ct2\/show\/NCT02580019"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0084|cit84","unstructured":"NCT03004976 Study of allogeneic umbilical cord blood infusion for adults with ischemic stroke (CoBIS 2) clinicaltrials.gov\/show\/NCT03004976"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0085|cit85","unstructured":"NCT03545607 MultiStem\u00ae administration for stroke treatment and enhanced recovery study (MASTERS-2) clinicaltrials.gov\/show\/NCT03545607"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0086|cit86","unstructured":"REgenerative Stem cell therapy for STroke in Europe www.resstore.eu\/about-resstore"},{"issue":"4","key":"10.1002\/14651858.CD007231.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/1747493017743057","article-title":"Treatment evaluation of acute stroke for using in regenerative cell elements (TREASURE) trial: rationale and design","volume":"13","author":"Osanai","year":"2018","journal-title":"International Journal of Stroke"},{"issue":"10046","key":"10.1002\/14651858.CD007231.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0140-6736(16)31259-4","article-title":"Age of PISCES: stem-cell clinical trials in stroke","volume":"388","author":"Borlongan","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD007231.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1161\/STROKEAHA.111.645986","article-title":"Eligibility for intravenous recombinant tissue-type plasminogen activator within a population: the effect of the European Cooperative Acute Stroke Study (ECASS) III trial","volume":"43","author":"R\u00edos la Rosa","year":"2012","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD007231.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.stem.2016.01.012","article-title":"Stem and progenitor cell-based therapy of the central nervous system: hopes, hype, and wishful thinking","volume":"18","author":"Goldman","year":"2016","journal-title":"Cell Stem Cell"},{"issue":"7454","key":"10.1002\/14651858.CD007231.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"GRADE Working Group","year":"2004","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0092|cit92","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"issue":"10069","key":"10.1002\/14651858.CD007231.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0140-6736(16)30962-X","article-title":"Stroke","volume":"389","author":"Hankey","year":"2017","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0094|cit94","unstructured":"Higgins JPT Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"8","key":"10.1002\/14651858.CD007231.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1161\/STROKEAHA.114.007803","article-title":"Stem cell-based tissue replacement after stroke: factual necessity or notorious fiction?","volume":"46","author":"Janowski","year":"2015","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD007231.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1161\/CIRCULATIONAHA.116.023336","article-title":"Treatment with tissue plasminogen activator in the golden hour and the shape of the 4.5-hour time-benefit curve in the National United States Get With The Guidelines-Stroke Population","volume":"135","author":"Kim","year":"2017","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neuint.2016.09.011","article-title":"Clinical trial design for stem cell therapies in stroke: what have we learned?","volume":"106","author":"Muir","year":"2017","journal-title":"Neurochemistry International"},{"issue":"1","key":"10.1002\/14651858.CD007231.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13287-017-0643-x","article-title":"Safety and effectiveness of stem cell therapies in early-phase clinical trials in stroke: a systematic review and meta-analysis","volume":"8","author":"Nagpal","year":"2017","journal-title":"Stem Cell Research and Therapy"},{"issue":"3","key":"10.1002\/14651858.CD007231.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1161\/STR.0000000000000158","article-title":"2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"49","author":"Powers","year":"2018","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007231.pub3-BIB0101|cit101","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"2","key":"10.1002\/14651858.CD007231.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/STROKEAHA.113.003379","article-title":"Stem cells as an emerging paradigm in stroke 3: enhancing the development of clinical trials","volume":"45","author":"Savitz","year":"2014","journal-title":"Stroke"},{"issue":"5","key":"10.1002\/14651858.CD007231.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1474-4422(09)70061-4","article-title":"Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic","volume":"8","author":"Zhang","year":"2009","journal-title":"Lancet Neurology"},{"issue":"3","key":"10.1002\/14651858.CD007231.pub3-BIB0104|cit104","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007231","article-title":"Stem cell transplantation for ischemic stroke","author":"Boncoraglio","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD007231.pub3-BIB0105|cit105","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007231.pub2","article-title":"Stem cell transplantation for ischemic stroke","author":"Boncoraglio","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD007231.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,15]],"date-time":"2023-01-15T04:32:40Z","timestamp":1673757160000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007231.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Stroke Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,5,5]]},"references-count":105,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007231.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,5]]}}}